Recall Atlas
Drugs & medicalType I

DRAXIMAGE MDP: Affected lot may contain particulate matter

Product quality

Read the official notice →
Date
2022-08-30
Country
Canada
Product
DRAXIMAGE MDP
Classification
Type I
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2022-08-31
  2. CA
    Drugs & medicalType II

    Evolve Modular Radial Head System - Cocr Stem Component

    Labelling and packaging

    Health CanadaOfficial notice →
  3. CA
    Drugs & medicalType II

    Omnilab Advanced and BiPAP A40

    Performance

    Health CanadaOfficial notice →
  4. CA
    Drugs & medicalType III

    Menopur: Out of specification (Assay)

    Product quality

    Health CanadaOfficial notice →
  5. 2022-08-29
  6. CA
    Drugs & medicalType I

    NERFASIN 20: Affected lot may contain the presence of particles

    Product quality

    Health CanadaOfficial notice →
  7. CA
    Drugs & medicalType I

    JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.

    Dosage - Labelling

    Health CanadaOfficial notice →
  8. CA
    Drugs & medical

    IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure

    New safety information - Product safety

    Health CanadaOfficial notice →
See all drugs & medical recalls →